Plunkett, W. “Rationale for the Design of Combination Therapies That Are Active in T-Cell Lymphomas?”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 2, no. 13, June 2009, doi:10.4081/hmr.v2i13.498.